![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
20
Nanyang Pukang Pharmaceutical Co., Ltd. Nanyang Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their significant offerings is Lincomycin hydrochloride, supported by a 'Withdrawn by EDQM Failure to CEP procedure' Certificate of Suitability (CEP) with the number R0-CEP 2013-114 - Rev 00
This Chemical Type CEP, issued on October 01, 2015, remains in force until November 29, 2017, ensuring its reliability within the pharmaceutical industry.
Substance Number 583 associated with this CEP further emphasizes